Modeling within-host HIV-1 dynamics and the evolution of drug resistance: trade-offs between viral enzyme function and drug susceptibility
From MaRDI portal
Publication:2219787
DOI10.1016/j.jtbi.2007.04.014zbMath1455.92087OpenAlexW2103813492WikidataQ36492224 ScholiaQ36492224MaRDI QIDQ2219787
Michael A. Gilchrist, Libin Rong, Alan S. Perelson, Zhilan Feng
Publication date: 21 January 2021
Published in: Journal of Theoretical Biology (Search for Journal in Brave)
Full work available at URL: http://europepmc.org/articles/pmc2265667
Related Items
Study of HIV mathematical model under nonsingular kernel type derivative of fractional order, Structure preserving numerical analysis of HIV and CD4+T-cells reaction diffusion model in two space dimensions, Dynamics of an HIV model with multiple infection stages and treatment with different drug classes, Analysis of a fractional model for HIV CD\(4^+\) T-cells with treatment under generalized Caputo fractional derivative, Modeling HIV persistence, the latent reservoir, and viral blips, An HIV infection model based on a vectored immunoprophylaxis experiment, Global dynamics of a delay virus model with recruitment and saturation effects of immune responses, Accounting for multi-delay effects in an HIV-1 infection model with saturated infection rate, recovery and proliferation of host cells, Global dynamics of an age-structured model for HIV viral dynamics with latently infected T cells, The global dynamics in a wild-type and drug-resistant HIV infection model with saturated incidence, Immune response in virus model structured by cell infection-age, Spatiotemporal dynamics of an HIV infection model with delay in immune response activation, Modeling the dynamics of HIV and \(CD4^{+}\)T cells during primary infection, Stability and Hopf bifurcation of HIV-1 model with Holling II infection rate and immune delay, Dynamic analysis of a fractional-order model for HIV with drug-resistance and CTL immune response, A within-host drug resistance model with continuous state-dependent viral strains, Stability of a CD4+ T cell viral infection model with diffusion, Numerical solution with analysis of HIV/AIDS dynamics model with effect of fusion and cure rate, Stability and bifurcation analysis of a fractional‐order model of cell‐to‐cell spread of HIV‐1 with a discrete time delay, Coupled within-host and between-host dynamics and evolution of virulence, Time-adaptive determination of drug efficacy in mathematical model of HIV infection, Stationary distribution and extinction of a stochastic HLIV model with viral production and Ornstein-Uhlenbeck process, Multiple cohort study of hospitalized SARS-CoV-2 in-host infection dynamics: parameter estimates, identifiability, sensitivity and the eclipse phase profile, A mathematical model for transmission dynamics of HIV/AIDS with effect of weak CD\(4^+\) T cells, Investigation of fractal-fractional HIV infection by evaluating the drug therapy effect in the Atangana-Baleanu sense, Mathematical modeling of viral infection dynamics in spherical organs, Global stability for an HIV-1 infection model including an eclipse stage of infected cells, Analysis of a CD4\(^+\) T cell viral infection model with a class of saturated infection rate, A discrete-time analog for coupled within-host and between-host dynamics in environmentally driven infectious disease, Resistance to protease inhibitors in a model of HIV-1 infection with impulsive drug effects, Unnamed Item, Stability analysis and numerical simulations of spatiotemporal HIV CD4+ T cell model with drug therapy, Unnamed Item, On the well-posedness of a fractional model of HIV infection, A fractional-order model of HIV infection with drug therapy effect, Vectored Immunoprophylaxis and Cell-to-Cell Transmission in HIV Dynamics, Complete classification of global dynamics of a virus model with immune responses, Approximate Analytical Solution of a HIV/AIDS Dynamic Model During Primary Infection, Emerging disease dynamics in a model coupling within-host and between-host systems, The effect of delay in viral production in within-host models during early infection, Global dynamics for viral infection model with Beddington-Deangelis functional response and an eclipse stage of infected cells, Global dynamics for a drug-sensitive and drug-resistant mixed strains of HIV infection model with saturated incidence and distributed delays, Modelling hepatotoxicity and antiretroviral therapeutic effect in HIV/HBV coinfection, Modeling the Effect of Reactive Oxygen Species and CTL Immune Response on HIV Dynamics, The modeling dynamics of HIV and CD4\(^{+}\) T-cells during primary infection in fractional order: numerical simulation, Modeling within-host viral dynamics: the role of CTL immune responses in the evolution of drug resistance, Modeling and stability analysis of HIV-1 as a time delay fuzzy T-S system via LMIs, The threshold for a stochastic HIV-1 infection model with Beddington-DeAngelis incidence rate, A delay-dependent model with HIV drug resistance during therapy, Stability and bifurcation analysis of an HIV-1 infection model with a general incidence and CTL immune response, Analysis and optimal control of an HIV model with logistic growth and infected cells in eclipse phase
Cites Work
- Unnamed Item
- Unnamed Item
- HIV-1 infection and low steady state viral loads
- Optimal viral production
- Understanding drug resistance for monotherapy treatment of HIV infection
- Modeling HIV dynamics and antiviral response with consideration of time-varying drug exposures, adherence and phenotypic sensitivity
- A delay-differential equation model of HIV infection of \(\text{CD}4^+\) T-cells
- Mathematical analysis of delay differential equation models of HIV-1 infection
- An age-structured model of HIV infection that allows for variations in the production rate of viral particles and the death rate of productively infected cells
- Dynamics of HIV infection of CD4\(^ +\) T cells
- A model for treatment strategy in the chemotherapy of AIDS
- A model of HIV-1 pathogenesis that includes an intracellular delay
- Complex patterns of viral load decay under antiretroviral therapy: influence of pharmacokinetics and intracellular delay
- Optimizing within-host viral fitness: infected cell lifespan and virion production rate
- Emergence of HIV-1 drug resistance during antiretroviral treatment
- Drug concentration heterogeneity facilitates the evolution of drug resistance
- Mathematical Analysis of HIV-1 Dynamics in Vivo
- Production of resistant HIV mutants during antiretroviral therapy
- Mathematical Analysis of Age‐Structured HIV‐1 Dynamics with Combination Antiretroviral Therapy
- TREATMENT INTERRUPTIONS AND RESISTANCE: A REVIEW